Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

481 - 490 of 3307 results found

Strategies to reduce the risks of mRNA drug and vaccine toxicity

Date
Wednesday, January 24, 2024 - 4:00 AM
Description
mRNA formulated with lipid nanoparticles is a transformative technology that has enabled the rapid development and administration of billions of coronavirus disease 2019 (COVID-19) vaccine doses worldwide. However, avoiding unacceptable toxicity with

SARS-CoV-2 neurovascular invasion supported by Mendelian randomization

Date
Wednesday, January 24, 2024 - 4:00 AM
Description
CONCLUSION: This work provides the first genetically predictive causal evidence between COVID-19 infection and inner retinal thickness in a European population. These findings will contribute to further understanding of the pathogenesis of COVID-19